Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
—
Political receipts
—
Lobbying income
—
Lobbying expense
—
Federal awards
—
Relationships
17
| insider of | Monte Rosa Therapeutics, Inc. | 19,950,000 | Jun 28, 2021 – Jun 28, 2021 |
| insider of | Regulus Therapeutics Inc. | 16,670,039.64 | May 7, 2019 – Dec 4, 2020 |
| insider of | Nkarta, Inc. | 11,999,988 | Jul 14, 2020 – Jul 14, 2020 |
| insider of | Marker Therapeutics, Inc. | 9,999,998.75 | Mar 16, 2021 – Mar 16, 2021 |
| insider of | Akouos, Inc. | 9,999,995 | Jun 30, 2020 – Jun 30, 2020 |
| insider of | Metacrine, Inc. | 9,999,990 | Sep 18, 2020 – Sep 18, 2020 |
| insider of | Achaogen, Inc. | 6,750,000 | Dec 19, 2016 – Dec 19, 2016 |
| insider of | Inc. Mirum Pharmaceuticals | 6,750,000 | Jul 22, 2019 – Jul 22, 2019 |
| insider of | Cascadian Therapeutics, Inc. | 5,999,400 | Feb 20, 2018 – Mar 9, 2018 |
| insider of | Eargo, Inc. | 5,599,998 | Oct 15, 2020 – Oct 12, 2022 |
| insider of | Inozyme Pharma, Inc. | 4,000,000 | Jul 25, 2020 – Jul 28, 2020 |
| insider of | Oruka Therapeutics, Inc. | 730,104.5 | Feb 26, 2018 – Feb 26, 2018 |